Krzysztof Selmaj - Publications, H-index & Citations

Krzysztof Selmaj

Center of Neurology

77H指数

539论文数

3.5W被引数

收录论文 94

发表时间

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis 奥比妥珠单抗在治疗初治受试者中的疾病结局：复发型多发性硬化受试者III期ULTIMATE I和II研究的亚组分析

Frontiers in Immunology

IF5.9

2026-05-30

OAAI

DR Derrick Robertson; EA Enrique Alvarez; LS Lawrence Steinman; HH Hans-Peter Hartung; PQ Peiqing Qian; KS Krzysztof Selmaj; SW Sibyl Wray; DW Daniel Wynn; EJ Edward J. Fox; KM Koby Mok; HP Hari P. Miskin; YX Yihuan Xu; CA Christopher A. Garner; BA Bruce A. C. Cree

Efficacy and safety of a bodyweight–adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials 奥瑞利珠单抗按体重调整的高剂量在复发型（MUSETTE）和原发进展型（GAVOTTE）多发性硬化中的疗效与安全性：两项多中心、随机、双盲、平行组3b期试验

The Lancet

IF88.5

2026-05-28

OAAI

Stephen L Hauser; Gavin Giovannoni; Xavier Montalban; Jiwon Oh; Amit Bar-Or; Maria Pia Sormani; Martin S Weber; Sharon Stoll; Jacqueline A Nicholas; Tetyana Nehrych; Robert Bonek; Krzysztof Selmaj; Maciej Maciejowski; Dusanka Zecevic; Catarina Raposo; Rebecca Owen; Ulrike Bonati; Katrin Madjar; Eva Harfst; Qing Wang

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis 一种新型的糖基工程化抗CD20单克隆抗体，用于治疗多发性硬化

Therapeutic Advances in Neurological Disorders

IF4.1

2026-03-30

PREAI

Krzysztof Selmaj; Ralf Gold; Igor Selmaj; Marcin P. Mycko

Novel homozygous SYNE1 missense variant in late onset autosomal recessive cerebellar ataxia 1: a case report 新型纯合子SYNE1错义变异在迟发性常染色体隐性小脑共济失调1型中的发现：一例病例报告

Therapeutic Advances in Neurological Disorders

IF4.1

2026-03-27

OAAI

Igor Selmaj; Nastassja Himmelreich; Krzysztof Selmaj

Neuro-behcet’s syndrome: epidemiology, mechanisms, and emerging strategies in diagnosis and treatment

Neurological Sciences

IF2.4

2026-03-17

PREAI

Emine Rabia Koc; Sanja Gluscevic; Abdulkadir Tunc; Meral Seferoglu; Christos Bakirtzis; Sara Samadzadeh; Krzysztof Selmaj; Hans-Peter Hartung; Xavier Montalban; Aksel Siva

Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study 复发型多发性硬化患者接受克拉屈滨片治疗后认知和就业的稳定性：两年期IV期CLARIFY-MS研究

Neurology and Therapy

IF4.8

2026-03-10

OAAI

Bruno Brochet; Dawn Langdon; Eva Kubala Havrdova; Jeanette Lechner-Scott; Xavier Montalban; Francesco Patti; Fredrik Piehl; Alessandra Solari; Raymond Hupperts; Nektaria Alexandri; Annette Lehn; Andrzej Smyk; Krzysztof Selmaj

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants 奥扎尼妥单抗停药后多发性硬化复发活动：DAYBREAK试验参与者的研究

Annals of Clinical and Translational Neurology

IF3.9

2026-03-01

OAAI

Gold, Ralf; Selmaj, Krzysztof W.; Berkovich, Regina; Cohen, Jeffrey A.; Comi, Giancarlo; Havrdova, Eva K.; Sheffield, James K.; Desai, Hetal; Cheng, Chun-yen; Riolo, Jon V.; Thorpe, Andrew; Deboer, Erik; Cree, Bruce A. C.

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial 奥扎尼妥（ozanimod）在复发型多发性硬化中的长期安全性与有效性：DAYBREAK开放标签扩展试验的最终分析

Multiple Sclerosis Journal

IF5

2025-11-05

OAAI

Krzysztof W Selmaj; Lawrence Steinman; Giancarlo Comi; Amit Bar-Or; Douglas L Arnold; Hans-Peter Hartung; Xavier Montalbán; Eva K Havrdová; James K Sheffield; Anthony Krakovich; Chun-Yen Cheng; Jon V Riolo; Chahin Pachai; Andrew Thorpe; Erik DeBoer; Ludwig Kappos; Jeffrey A Cohen; Bruce AC Cree

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials 奥扎尼妥单抗治疗复发型多发性硬化患者的脑萎缩及其与长期残疾和认知功能的关系：来自III期和开放标签扩展试验的结果

Multiple Sclerosis Journal

IF5

2025-07-23

PREAI

Jeffrey A Cohen; Douglas L Arnold; John DeLuca; Hans-Peter Hartung; Ludwig Kappos; Giancarlo Comi; Krzysztof Selmaj; Lawrence Steinman; Amit Bar-Or; Xavier Montalban; Eva K Havrdová; James K Sheffield; Chahin Pachai; Chun-Yen Cheng; Jon V Riolo; Bruce AC Cree

Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress

BIOMEDICINES

IF3.9

2025-02-04

OAAI

Ricigliano, Vito A. G.; Marenna, Silvia; Borrelli, Serena; Camera, Valentina; Contentti, Edgar Carnero; Szejko, Natalia; Bakirtzis, Christos; Gluscevic, Sanja; Samadzadeh, Sara; Hartung, Hans-Peter; Selmaj, Krzysztof; Stankoff, Bruno; Comi, Giancarlo; ECF Young Investigators Fellows Initiative

Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab

BIODRUGS

IF6.9

2024-09-30

OAAI

Selmaj, Krzysztof; Roth, Karsten; Hoefler, Josef; Vitzithum, Klaus; Derlacz, Rafal; von Richter, Oliver; Hornuss, Cyrill; Poetzl, Johann; Singer, Barry; Jacobs, Laura

Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial

MULTIPLE SCLEROSIS JOURNAL

IF5

2023-12-21

OAAI

Naismith, Robert T.; Cohen, Jeffrey A.; Bar-Or, Amit; Comi, Giancarlo; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Sheffield, James K.; Krakovich, Anthony; Tatosian, Daniel; Cheng, Chun-Yen; Reardon, Jennifer; Khaychuk, Vadim; Riolo, Jon, V; Silva, Diego; Cree, Bruce A. C.

Pregnancy Outcomes in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis: Results From the Ozanimod Clinical Development Program

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2023-12-01

OAAI

Dubinsky, Marla C.; Charles, Lorna; Selmaj, Krzysztof W.; Comi, Giancarlo; Krakovich, Anthony; Rosen, Melissa; Van Der Woude, C. Janneke; Mahadevan, Uma

Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

MULTIPLE SCLEROSIS JOURNAL

IF5

2023-11-18

OAAI

Brochet, Bruno; Solari, Alessandra; Lechner-Scott, Jeannette; Piehl, Fredrik; Langdon, Dawn; Hupperts, Raymond; Selmaj, Krzysztof; Patti, Francesco; Brieva, Luis; Maida, Eva Maria; Alexandri, Nektaria; Smyk, Andrzej; Nolting, Axel; Keller, Birgit; Montalban, Xavier; Kubala Havrdova, Eva

Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

MULTIPLE SCLEROSIS JOURNAL

IF5

2023-10-31

OAAI

Singer, Barry A.; Arnold, Douglas L.; Drulovic, Jelena; Freedman, Mark S.; Gold, Ralf; Gudesblatt, Mark; Jasinska, Elzbieta; Laganke, Christopher C.; Naismith, Robert T.; Negroski, Donald; Oh, Jiwon; Perez, Miguel Angel Hernandez; Selmaj, Krzysztof; Bergh, Florian Then; Wundes, Annette; Ziemssen, Tjalf; Castro-Borrero, Wanda; Chen, Hailu; Levin, Seth; Scaramozza, Matthew; Shankar, Sai L.; Wang, Ting; Wray, Sibyl

Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis

NEUROLOGY

IF8.5

2023-04-25

PREAI

Naismith, Robert T.; Cohen, Jeffrey A.; Bar-Or, Amit; Comi, Giancarlo; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Sheffield, James K.; Krakovich, Anthony; Cheng, Chun-Yen; Reardon, Jennifer; Riolo, Jon V.; Silva, Diego; Cree, Bruce A. C.

Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies Ublituximab在3期终极I和II研究中对复发性多发性硬化症的初治参与者的疗效

NEUROLOGY

IF8.5

2023-04-25

PREAI

Steinman, Lawrence; Fox, Edward; Hartung, Hans-Peter; Alvarez, Enrique; Qian, Peiqing; Wray, Sibyl; Robertson, Derrick; Huang, Deren; Selmaj, Krzysztof; Wynn, Daniel; Bosco, Jenna; Mok, Koby; Garner, Christopher A.; Cree, Bruce

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2022-08-25

OAAI

Steinman, Lawrence; Fox, Edward; Hartung, Hans-Peter; Alvarez, Enrique; Qian, Peiqing; Wray, Sibyl; Robertson, Derrick; Huang, DeRen; Selmaj, Krzysztof; Wynn, Daniel; Cutter, Gary; Mok, Koby; Hsu, Yanzhi; Xu, Yihuan; Weiss, Michael S.; Bosco, Jenna A.; Power, Sean A.; Lee, Lily; Miskin, Hari P.; Cree, Bruce A. C.

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations

MULTIPLE SCLEROSIS JOURNAL

IF5

2022-08-24

PREAI

Brownlee, Wallace J.; Wolf, Christian; Hartung, Hans-Peter; Dingermann, Theo; Anshasi, Nadia; Clark, Richard A. C.; Trojano, Maria; Selmaj, Krzysztof; Uitdehaag, Bernard M. J.; Tur, Carmen; Wuerfel, Jens; Dallmann, Gabriele; Witte, Julian; Sintzel, Martina; Bobrovnikova, Olga; Cohen, Jeffrey A.

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

MULTIPLE SCLEROSIS JOURNAL

IF5

2022-06-28

OAAI

Cree, Bruce A. C.; Selmaj, Krzysztof W.; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L.; Hartung, Hans-Peter; Montalban, Xavier; Havrdova, Eva K.; Sheffield, James K.; Minton, Neil; Cheng, Chun-Yen; Silva, Diego; Kappos, Ludwig; Cohen, Jeffrey A.

研究方向